TBABF(TBABF)
TBABF
No analyst ratings available
No analyst price targets available for TBABF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $36.71B | $39.23B | $40.97B | $41.71B |
| Low | $36.40B | $38.44B | $40.38B | $41.10B |
| High | $37.12B | $40.02B | $41.62B | $42.37B |
| EBITDA Avg | $8.11B | $9.09B | $9.76B | $10.31B |
| Low | $8.00B | $8.96B | $9.62B | $10.17B |
| High | $8.22B | $9.22B | $9.91B | $10.48B |
| EBIT Avg | $6.14B | $7.14B | $7.82B | $8.37B |
| Low | $6.03B | $7.02B | $7.68B | $8.22B |
| High | $6.26B | $7.28B | $7.97B | $8.53B |
| Net Income Avg | $4.52B | $5.32B | $5.87B | $6.31B |
| Low | $4.43B | $5.22B | $5.76B | $6.19B |
| High | $4.61B | $5.43B | $5.99B | $6.44B |
| EPS Avg | $19.81 | $23.33 | $25.72 | $27.65 |
| Low | $19.44 | $22.89 | $25.23 | $27.13 |
| High | $20.22 | $23.81 | $26.25 | $28.22 |
| Analysts (Rev / EPS) | 9 / 3 | 10 / 2 | 4 / 3 | 5 / 3 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 |
|---|---|---|---|---|
| Revenue Avg | $9.35B | $9.41B | $9.53B | $9.93B |
| Low | $9.24B | $9.22B | $9.38B | $9.78B |
| High | $9.54B | $9.65B | $9.75B | $10.16B |
| EBITDA Avg | $2.00B | $2.03B | $2.02B | $2.18B |
| Low | $1.97B | $2.00B | $1.99B | $2.15B |
| High | $2.05B | $2.08B | $2.06B | $2.23B |
| EBIT Avg | $1.50B | $1.53B | $1.52B | $1.69B |
| Low | $1.47B | $1.50B | $1.49B | $1.65B |
| High | $1.54B | $1.58B | $1.56B | $1.73B |
| Net Income Avg | $1.14B | $1.17B | $1.16B | $1.30B |
| Low | $1.12B | $1.15B | $1.14B | $1.27B |
| High | $1.18B | $1.21B | $1.19B | $1.33B |
| EPS Avg | $5.13 | $5.25 | $5.19 | $5.80 |
| Low | $5.02 | $5.14 | $5.09 | $5.68 |
| High | $5.28 | $5.41 | $5.35 | $5.98 |
| Analysts (Rev / EPS) | 6 / 1 | 6 / 1 | 3 / 1 | 3 / 1 |